Polimed Ltd.

What Polimed Ltd. does

Polimed Ltd. is a privately held Polish medical device distributor founded in 1994 and headquartered in Warsaw. The company exclusively represents multiple international medical device manufacturers for the Polish market, distributing cardiovascular and neurovascular devices to hospitals, cardiology centers, neuroradiology departments, and specialist physicians. Its portfolio spans structural heart closure systems (Occlutech PFO, ASD, VSD, PDA devices; Occlutech AFR atrial flow regulator), coronary sinus flow reduction (Neovasc REDUCER), neurointerventional devices (Rapid Medical Tigertriever family and Comaneci; Lepu Medical Perdenser/Perfiller coils, Frepass microcatheter, Deromper controller; MIVI Neuro Q aspiration catheter and Super 90 guide catheter; Cerus Endo Contour and Neqstent devices), TAVI imaging systems (Symedrix INNOVI and INNOVI SX), and radiation protection accessories (InFab Corp lead aprons, glasses, thyroid shields, and caps).

The company generates revenue through hardware sales of these distributed devices under a B2B enterprise go-to-market model: direct field sales to hospitals and cardiology centers across Poland, with quote-based pricing on devices and accessories. Polimed reports its supplied equipment has been used in 6,000+ structural heart procedures and 25,000+ coronary procedures, and positions itself as a long-tenured partner involved in product development from early conceptual phases alongside its OEM principals. The group also includes a wholly-owned R&D subsidiary, Polimed Research Sp. z o.o., focused on medical technology research, indicating intent to evolve beyond pure distribution. All activity is currently Poland-domiciled, with the company identifying as a Central European operator serving the Polish market.

Name

Polimed Ltd.

Legal name

Polimed

Website

https://polimed.com.pl

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

Polimed Ltd. is a Polish medical device distributor founded in 1994 that exclusively represents international cardiovascular and neurovascular device OEMs, supplying structural heart, stroke intervention, TAVI imaging, and radiation protection products to hospitals and cardiology centers across Poland.

Ownership category

akta.pro rank

Product category

Medical Device Distribution

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Medical Equipment and Supplies Manufacturing (33911), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro industry

PRIMARYHLAHAFAJ

Thrombectomy, Embolic Protection & Stroke Intervention Devices

Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

SECONDARYHLAHAFAB

Structural Heart Valves (TAVR/SAVR) & Valve Repair

Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

SECONDARYHLAHAFAL

Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

• Medical device distribution
• Cardiovascular devices
• Neurovascular devices
• Structural heart devices
• Neuroradiology equipment

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Device Distribution: Polimed generates revenue through distributing innovative medical devices to hospitals and cardiology centers across Poland. As a distributor of multiple international medical device brands, they supply structural heart devices, neuroradiology equipment, and other cardiovascular medical technologies to healthcare institutions.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Polimed Ltd. is a Polish medical device distributor that introduces innovative cardiovascular and neurovascular devices from international manufacturers to hospitals, cardiology centers, and specialist physicians across Poland. The company supplies structural heart devices (PFO, ASD, VSD, PDA closure systems, AFR, REDUCER), neurointerventional devices for stroke treatment (mechanical thrombectomy stent retrievers, embolic coils, microcatheters), aspiration and guide catheters, TAVI imaging systems, and radiation protection equipment. Since 1994, Polimed has collaborated with device developers from early conceptual phases and provides Polish clinical institutions with access to breakthrough vascular therapies.

Product overview

Polimed Ltd. is a Polish medical technology distributor that introduces innovative cardiovascular and neurovascular devices to clinical practice in Poland. The company operates as a portfolio of distributed products rather than a unified platform, offering: (1) Structural heart devices including PFO, ASD, VSD, and PDA closure systems from Occlutech, plus the AFR atrial flow regulator and REDUCER coronary sinus flow reducer from Neovasc; (2) Neurointerventional devices for stroke treatment including Rapid Medical's Comaneci and Tigertriever stent retrievers, and Lepu Medical's embolic coils (Perdenser, Perfiller), microcatheters (Frepass), and coil detachment controllers (Deromper); (3) Aspiration and guide catheters from MIVI Neuro including the Q Aspiration Catheter and Super 90 Guide Catheter; (4) Cardiovascular imaging systems INNOVI and INNOVI SX from Symedrix for TAVI procedures; and (5) Radiation protection equipment including lead aprons, glasses, thyroid shields, and caps from INFAB. The company collaborates with device developers from conceptual phases through clinical implementation, with products used in cardiac structural procedures, coronary interventions, and neuroradiological treatments across Poland since 1994.

Differentiator

Problem solved

Functional benefit

Brands

• Polimed Research: Research and development subsidiary focused on medical technology R&D projects

Products and services

• Occlutech Structural Heart Closure Devices (PFO, ASD, VSD, PDA)
• Occlutech AFR (Atrial Flow Regulator)
• PLD (Novel Structural Heart Device)
• Neovasc REDUCER Coronary Sinus Flow Reducer
• Rapid Medical Comaneci Embolic Assist Device
• Rapid Medical Tigertriever Family of Stent Retrievers
• Lepu Medical Perdenser Embolic Coil System
• Lepu Medical Perfiller Expansible Embolic Coil System
• Lepu Medical Frepass Disposable Microcatheter
• Lepu Medical Deromper Coil Detachment Controller
• MIVI Neuro Q Aspiration Catheter
• MIVI Neuro Super 90 8F Guide Catheter
• Symedrix INNOVI and INNOVI SX TAVI Systems
• Cerus Endovascular Contour Neurovascular System
• Cerus Endovascular Neqstent Bridging Device
• Percutaneous Left Atrium Appendage Closure Systems
• INFAB Radiation Protection Equipment

Quantifiable outcome

• 6000+ structural heart procedures performed with supplied equipment
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core, major and minor.

• OcclutechcoreChannel Partner/ Reseller/ DistributorPolimed distributes Occlutech products in Poland including PFO (patent foramen ovale) closure devices, ASD (atrial septal defect) devices, and AFR devices for cardiac treatments.
• Rapid MedicalcoreChannel Partner/ Reseller/ DistributorPolimed distributes Rapid Medical neurovascular devices including Comaneci, Tigertriever, Tigertriever 13, and Tigertriever XL for stroke treatment.
• NeovasccoreChannel Partner/ Reseller/ DistributorPolimed distributes Neovasc REDUCER device - a flow reducer implanted into the coronary sinus for cardiac treatment.
• Lepu MedicalmajorChannel Partner/ Reseller/ DistributorPolimed distributes Lepu Medical neurointerventional products including Perdenser Embolic Coil System, Perfiller Expansible Embolic Coil System, Frepass Disposable Microcatheter, and Deromper Coil Detachment Controller.
• MIVI NeuromajorChannel Partner/ Reseller/ DistributorPolimed distributes MIVI Neuro products including Q Aspiration Catheter and Super 90 8F Guide Catheter for neurovascular procedures.
• Cerus EndomajorChannel Partner/ Reseller/ DistributorPolimed distributes Cerus Endo neurovascular products including Contour Neurovascular System and Neqstent Bridging Device.
• SymedrixmajorChannel Partner/ Reseller/ DistributorPolimed distributes Symedrix products INNOVI and INNOVI SX for TAVI procedures.
• InFab CorpminorChannel Partner/ Reseller/ DistributorPolimed distributes InFab Corp radiation protection products including lead aprons, lead glasses, thyroid shields, and lead caps.

Scale indicators3 records

Recent moves6 records

Expansion highlights3 records

Broad incumbents

• W. L. Gore & Associates: Gore manufactures the GORE Cardioform Septal Occluder, a direct product-level competitor to Occlutech's PFO and ASD closure devices that Polimed distributes. As a privately held broad-incumbent with established cardiovascular franchises, Gore competes for the same clinical accounts Polimed serves.
• Abbott Laboratories: Abbott's Structural Heart and Cardiac Arrhythmias businesses include the Amplatzer septal occluder family—the closest direct competitor to the PFO/ASD/VSD/PDA occluders Polimed supplies in Poland. Abbott sells directly in Poland via its own commercial organization.
• Boston Scientific Corporation: Boston Scientific is a major cardiovascular portfolio company, including the Watchman left-atrial-appendage closure system which directly competes with the percutaneous LAA closure devices Polimed distributes from Occlutech. It operates in Poland through its own distribution network.
• TERUMO Corporation: TERUMO manufactures guidewires, microcatheters, and neurovascular access devices overlapping with MIVI Neuro's Super 90 guide catheter and Lepu Medical's Frepass microcatheter that Polimed supplies. As a broad cardiovascular incumbent with Polish-market presence, TERUMO competes for interventional cardiology and neuroradiology business.
• Edwards Lifesciences: Edwards is the global leader in transcatheter aortic valve replacement (TAVR/TAVI), the procedure space for which Polimed distributes the Symedrix INNOVI/INNOVI SX imaging systems. As a broad structural-heart incumbent, Edwards is the dominant competitor in the therapy categories Polimed supports.
• Medtronic plc: Medtronic manufactures structural heart valves (TAVR), left-atrial-appendage closure systems, and neurovascular devices spanning the same procedures Polimed's portfolio supports. It is a large incumbent that competes on overlapping product lines and could in principle field its own Polish distribution.
• Stryker Corporation (Neurovascular): Stryker's Neurovascular division supplies stent retrievers, aspiration catheters, and access devices for stroke intervention globally, overlapping directly with the Rapid Medical and MIVI Neuro product families Polimed brings to Poland. As a broad incumbent medtech, Stryker competes for the same hospital contracts at the European level.
• Cerenovus (Johnson & Johnson MedTech): Cerenovus is J&J's neurovascular business, offering embolic coils, flow diverters, and stroke intervention devices—the same categories as the Lepu Medical and Rapid Medical portfolios Polimed distributes. It is a broad incumbent competitor across the neurovascular procedures Polimed supports.

Direct peers

• Penumbra Inc. Penumbra manufactures aspiration catheters and stent retrievers for mechanical thrombectomy in acute ischemic stroke—the same clinical category in which Polimed distributes MIVI Neuro's Q Aspiration Catheter and Rapid Medical's Tigertriever devices. It is a direct channel-level and product-line competitor within the Polish neurovascular market.

Emerging players

• MicroPort Scientific Corporation: MicroPort is an emerging structural-heart and cardiovascular player with growing TAVR and occlusion device franchises. Its product trajectory intersects with Polimed's manufacturer partners and gives it potential as both a future partner or competitor in the Central European structural-heart channel.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/polimed-sp-z-o-o

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Polimed Ltd.